View Larger
Griffith Harsh
Academic Appointments
- Professor - Med Center Line, Neurosurgery
- Member, Bio-X
- Member, Stanford Cancer Institute
- Professor - Med Center Line (By courtesy), Otolaryngology (Head and Neck Surgery)
Key Documents
Contact Information
-
Clinical Offices
Neurosurgery 875 Blake Wilbur Dr Clinic D Stanford, CA 94305 Tel Work (650) 736-7440 Fax (650) 498-4686Practices at Stanford Hospital and Clinics and Lucile Packard Children's Hospital
- Academic Offices
Personal Information Email Tel (650) 725-0701Not for medical emergencies or patient use
Professional Overview
Clinical Focus
- Cancer> Neuro Oncology
- Acoustic Neuroma
- Acoustic Neuroma - Head and Neck Surgery
- Brain / Central Nervous System Tumors
- Brain / Central Nervous System Tumors - Neuro Oncology
- Brain / Central Nervous System Tumors - Neurosurgery
Administrative Appointments
- Director, Stanford Brain Tumor Center (2010 - present)
- Associate Dean, CME Education, Stanford University School of Medicine (2012 - present)
- Program Director, Stanford Neurosurgery Resident Training Program (2004 - 2006)
- Surgical Director, Stanford Pituitary Center (2004 - 2006)
- Director, Stanford Surgical Neuro-oncology (1998 - 2006)
Honors and Awards
- Excellence in Resident Teaching, Stanford Neurosurgery (2000)
- Outstanding Teacher Award, MGH Neurosurgery (1994)
- Golden Amygdala Teaching Award, UCSF Neurosurgery (1990)
- Rhodes Scholarship, Rhodes Trust (1975-1978)
Professional Education
| Fellowship: | University of Pittsburgh School of Medicine PA (1990) |
| Board Certification: | Neurological Surgery, American Board of Neurological Surgery (1989) |
| Residency: | UCSF Medical Center CA (1986) |
| Fellowship: | UCSF Medical Center CA (1985) |
| Internship: | UCSF Medical Center, CA USA (1981) |
| Medical Education: | Harvard Medical School MA (1980) |
Graduate & Fellowship Program Affiliations
Scientific Focus
Current Research Interests
Microsurgical treatment of tumors of the brain, spinal cord, pituitary gland and skull base;
Radiosurgery of tumors;
Molecular biology of brain tumors.
Clinical Trials
- Phase I Vorinostat Concurrent with Stereotactic Radiosurgery (SRS) in Brain Metastases from Non-Small Cell Lung Cancer Recruiting
- PI/II of Temozolomide & Hypofractionated Radiotherapy in Tx of Supratentorial Glioblastoma Multiform Recruiting
- Phase I/II Study of Fractionated Stereotactic Radiosurgery to Treat Large Brain Metastases Recruiting
- An Open-Labeled, Extended-Use of XERECEPT (hCRF) for Patients in Studies NTI 0302, 0303, or Other Designated Studies Completed
- Phase I Trial of Arsenic Trioxide and Stereotactic Radiotherapy for Recurrent Malignant Glioma Completed
Publications
- Cochlea Radiation Dose Correlates with Hearing Loss After Stereotactic Radiosurgery of Vestibular Schwannoma. World Neurosurg. 2012
- Management of intracranial and extracranial chordomas with CyberKnife stereotactic radiosurgery. J Clin Neurosci. 2012; (8): 1101-6
- Mucocele formation under pedicled nasoseptal flap. Am J Otolaryngol. 2012; (5): 634-6
- Stereotactic radiosurgery of the postoperative resection cavity for brain metastases: prospective evaluation of target margin on tumor control. Int J Radiat Oncol Biol Phys. 2012; (2): 336-42
- The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors. Proc Natl Acad Sci U S A. 2012; (17): 6662-7
- What is the optimal treatment of large brain metastases? An argument for a multidisciplinary approach. Int J Radiat Oncol Biol Phys. 2012; (3): 688-93
Help